MycoTeQ mycoteq.com


Public lists: Pharma Startups (4732)

MycoTeQ discovers and develops natural antibiotics against gram-negative bacteria. The pipeline of the company is based on natural small molecules produced by microfungi. A compound library representing microfungi from a range of biological niches forms the core of the discovery process.

MycoTeQ discovers and develops natural antibiotics against gram-negative bacteria. The pipeline of the company is based on natural small molecules produced by microfungi. A compound library representing microfungi from a range of biological niches fo...Show all

Company (Alive / Active)

Phone:

Fax:

Søltofts Plads 221
2800
Denmark

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MycoTeQ $0M Nov 30, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MycoTeQ Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

KAI Pharmaceuticals

South San Francisco, California, United States
AcquiredKAI Pharmaceuticals is a privately held, venture-backed drug discovery and development company with preclinical and clinical programs in acute cardiovascular and other diseases representing unmet medical needs. The company has applied its core expertise in the biology of PKC to develop highly potent and selective inhibitors and activators for each of the PKC isozymes for the treatment of a broad array of human diseases. KAI has received Fast-Track designation from the FDA for its lead compound, ...Show allLogin to see details

Stemina Biomarker Discovery

Madison, Wisconsin, United States
Alive / ActiveStemina Cell Discovery discovers and validates small molecules as biomarkers for high-throughput drug screening and disease diagnostics using an all human system comprised of stem cells and the company's metabolomics platform. Metabolomics aims to enable the discovery of small molecules that can be used as candidate biomarkers of disease and pharmacological efficacy or toxicity. The human embryonic stem cell metabolome is a source of candidate biomarkers to predict, diagnose or measure the progr...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)